Each year, a summary report is generated to document the Annual WRI Meeting in order to best provide direction for WRI's ongoing work to advance the research for HIV+ women. Building on the growing momentum of recent WRI accomplishments, the 2006 meeting focused on two key concepts: first, identifying the most critical constraints to accelerating progress in research and second, focusing our efforts only on those specific constraints within our direct sphere of influence. This approach helped the WRI to zero in on a few key initiatives for the coming year. These initiatives can be broadly described as addressing two basic questions:
- What things do we not know that, if known, could significantly impact the course of the epidemic?
- What things do we know which, if broadly disseminated, could significantly impact the course of the epidemic?
To accomplish this, the WRI identified initiatives in three areas:
- Research "policies, practices, and priorities"
- Clinical Trial Network Accountability
- Community engagement and leadership development
Attending the meeting were members of the WRI (including representatives from clinical care, HIV research, academia, community-based organizations, government, the pharmaceutical industry and HIV-positive women), guest speakers and invited experts. A list of the 2006 WRI Meeting members, speakers and participants can be found below.
2006 WRI Meeting Participants
| Richard Averitt The Well Project |
Julie Barroso Duke University School of Nursing |
| Dawn Averitt Bridge The Well Project |
Gina Brown, MD Maternal-Fetal Specialist New York City Department of Health and Mental Hygiene |
| Rebecca Clark, MD LSU HSC |
Susan Ellen Cohn, MD, MPH Associate Professor of Medicine University of Rochester |
| Elizabeth Connick, MD Associate Professor of Medicine University of Colorado at Denver and Health Sciences Center |
Robert W. Coombs, MD, PhD, FRCPC Professor, Laboratory Medicine & Medicine University of Washington |
| Terri Creagh, PhD Director of Research Clinical and Epidemiologic Research |
Kristy Grimm Associate Director, Virology Medical Strategy Bristol-Myers Squibb |
| Jane Hitti, MD Associate Director University of Washington Medical Center, Dept. Ob/Gyn |
Sally L. Hodder, MD University of Medicine & Dentistry of New Jersey |
| Katherine Hollinger, DVM, MPH FDA/Office of Women's Health |
Rowena Johnston, PhD Director, Research AmfAR – The Foundation for AIDS Research |
| Ben Kozub Boehringer Ingelheim |
Sharon Lee Director Family Health Care |
| Meagan Lyon, MPH Senior Research Assistant Forum for Collaborative HIV Research |
Cathy Olufs Education Director The Center for Health Justice (formerly CorrectHELP) |
| Andrew Pavia, MD Professor and Chief, Division of Pediatric Infectious Disease University of Utah |
Martell Randolph Community Educator AIDS Research Alliance |
| Claire Rappaport Community Liaison International Network for Strategic Initiative in Global HIV Trials (INSIGHT) |
Patricia Reichelderfer NIH/NICHD |
| Wendy Rhein Executive Director The Well Project |
Alex Rinehart Associate Medical Director Tibotec Therapeutics |
| Yolanda Rodriguez-Escobar Executive Director Mujeres Unides Corba el SIDA |
Ellie Schoenbaum, MD Director of AIDS Research Program Montefiore Medical Center |
| Stephen P. Storfer, MD Senior Associate Director, Virology Boehringer Ingelheim Pharmaceuticals, Inc. |
Kimberly Struble, PharmD Medical Team Leader Food and Drug Administration, Division of Antiviral Products |
| Melanie Thompson, MD Principal Investigator AIDS Research Consortium of Atlanta |
Fulvia Veronese, PhD Chair, HIV/AIDS Etiology and Pathogenesis Coordinating Committee NIH, Office of AIDS Research |
| Ron Wilder President Aligned Action, Inc. |
